Coste-Burel M, Besse B, Moreau A, Imbert B M, Mensier A, Sagot P, Lopes P, Billaudel S
Laboratoire de Virologie, Women and Children's Hospital, CHU-44035 Nantes, France.
Eur J Obstet Gynecol Reprod Biol. 1993 Dec 30;52(3):193-200. doi: 10.1016/0028-2243(93)90071-j.
Polymerase chain reaction (PCR) was used to identify human papillomavirus (HPV) in 216 cervical biopsy specimens from women referred to the gynecological out-patient unit for colposcopy because of an abnormal smear. HPV DNA was screened using type-specific primers for HPV6, 11, 16, 18, 31 and 33 (TS-PCR) as well as a consensus primer located in the E1 region of the HPV genome (C-PCR). TS-PCR specificity was validated by Southern blot analysis. Low-grade (SIL 1) and high-grade (SIL 2) squamous intraepithelial lesions were found in 165 biopsies. HPV16 detection was better with PCR than Southern blot, particularly for SIL 1 and SIL 2. The fact that 10% of HPV16 (all SIL 2) were not detected by C-PCR indicates that both PCR techniques should be performed. C-PCR also detects uncharacterized HPV types (8.6% prevalence in our results), mainly in SIL 1 and SIL 2. HPV16, the most frequently isolated type (prevalence 21%), was associated with SIL 2 in 83% of cases. A low HPV prevalence was found in specimens without dysplastic cells. These results suggest that PCR may be an important tool for identifying women at risk for developing dysplasia or cervical cancer.
聚合酶链反应(PCR)用于对216份宫颈活检标本进行人乳头瘤病毒(HPV)鉴定,这些标本来自因涂片异常而转诊至妇科门诊进行阴道镜检查的女性。使用针对HPV6、11、16、18、31和33的型特异性引物(TS-PCR)以及位于HPV基因组E1区域的共有引物(C-PCR)对HPV DNA进行筛查。TS-PCR的特异性通过Southern印迹分析进行验证。165份活检标本中发现了低级别(SIL 1)和高级别(SIL 2)鳞状上皮内病变。PCR检测HPV16的效果优于Southern印迹法,尤其是对于SIL 1和SIL 2。10%的HPV16(均为SIL 2)未被C-PCR检测到,这表明两种PCR技术都应进行。C-PCR还可检测未分型的HPV类型(在我们的结果中患病率为8.6%),主要存在于SIL 1和SIL 2中。最常分离出的HPV16型(患病率为21%)在83%的病例中与SIL 2相关。在无发育异常细胞的标本中发现HPV患病率较低。这些结果表明,PCR可能是识别有发育异常或宫颈癌风险女性的重要工具。